84 related articles for article (PubMed ID: 22646001)
1. [Relations between red cell structure, function and immune homeostasis in prostatic diseases].
Shatokhin MN; Teodorovich OV; Konoplia AI; Dolgareva SA; Gavriliuk VP; Krasnov LV; Mavrin MIu
Urologiia; 2012; (1):42-6. PubMed ID: 22646001
[TBL] [Abstract][Full Text] [Related]
2. [Correction of local immunometabolic disturbances combined with chronic prostatitis in prostatic adenoma].
Teodorovich OV; Shatokhin MN; Mal'tsov VN; Konoplia AI; Loktiononv AL; Krasnov AV
Urologiia; 2010; (5):22-6. PubMed ID: 21254636
[TBL] [Abstract][Full Text] [Related]
3. [Structural and functional characteristics of erythrocytes, endothelial dysfunction and lipid peroxidation in patients with prostatic adenoma and comorbid chronic prostatitis].
Shatokhin MN; Teodorovich OV; Konoplia AI; Dolgareva SA; Gavriliuk VP
Urologiia; 2011; (1):31-4. PubMed ID: 21500492
[TBL] [Abstract][Full Text] [Related]
4. [Effects of chronic bacterial prostatitis on changes in concentration and free and total prostatic specific antigen in the serum and urine from patients with benign prostatic hyperplasia and prostatic cancer].
Mazo EB; Grigor'ev ME; Stepenskiĭ AB
Urologiia; 2001; (5):3-7. PubMed ID: 11641977
[TBL] [Abstract][Full Text] [Related]
5. [Impact of prostatic benign hyperplasia and prostatic inflammation on the increase of prostate specific antigen levels].
Ferrero Doria R; Pérez Flores D; Terrer Artes C; Guzmán Martínez-Valls PL; Morga Egea JP; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Fontana Compiano LO
Actas Urol Esp; 1997 Feb; 21(2):100-4. PubMed ID: 9214204
[TBL] [Abstract][Full Text] [Related]
6. [Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis].
Seregin SP; Bratchikov OI; Konoplia AI; Shestakov SG; Dolzhenkov SD; Novikov AV; Shatokhin MN; Kotov AV
Urologiia; 2002; (4):14-6. PubMed ID: 12357892
[TBL] [Abstract][Full Text] [Related]
7. Antiprostasome antibody titres in benign and malignant prostate disease.
Minelli A; Ronquist G; Carlsson L; Mearini E; Nilsson O; Larsson A
Anticancer Res; 2005; 25(6C):4399-402. PubMed ID: 16334115
[TBL] [Abstract][Full Text] [Related]
8. [The mechanism of the action of local transrectal hyperthermia in treating prostatic adenoma].
Mazo EB; Kudriavtsev IuV; Petukhov EB; Samuilova DSh; Krivoborodov GG
Urol Nefrol (Mosk); 1994; (1):45-9. PubMed ID: 7515535
[TBL] [Abstract][Full Text] [Related]
9. [Determination of serum Fe in prostatic pathology].
Picurelli L; Olcina PV; Roig MD; Molina E; Ferrer J
Actas Urol Esp; 1990; 14(4):262-3. PubMed ID: 1702257
[TBL] [Abstract][Full Text] [Related]
10. Serum sodium and chloride in prostatic hypertrophy and cancer.
Casey AE; Gilbert FE; Downey EL; Thomason S; Deacy JV
Ala J Med Sci; 1970 Jan; 7(1):109-10. PubMed ID: 4193657
[No Abstract] [Full Text] [Related]
11. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
12. Measurements of prolactin and androgens in patients with prostatic disease.
Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
Surg Forum; 1977; 28():568-9. PubMed ID: 83009
[No Abstract] [Full Text] [Related]
13. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
[TBL] [Abstract][Full Text] [Related]
14. [Upgrading of clinicoimmunological effectiveness of combined treatment in patients with chronic prostatitis].
Bratchikov OI; Shestakov SG; Shumakova EA; Makhov SV
Urologiia; 2008; (2):44-8. PubMed ID: 18572770
[TBL] [Abstract][Full Text] [Related]
15. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
Pawlicki B; Zieliński H; Dabrowski M
Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
[TBL] [Abstract][Full Text] [Related]
16. [How should an elevated blood level of prostate-specific antigen be interpreted?].
Boccon-Gibod L
Rev Med Suisse Romande; 1992 Nov; 112(11):955-6. PubMed ID: 1281334
[No Abstract] [Full Text] [Related]
17. [Prostatic specific antigen in the serum in prostatic cancer].
Fuse H; Akakura K; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1987 Jul; 33(7):1049-53. PubMed ID: 2446484
[TBL] [Abstract][Full Text] [Related]
18. [Value of prostate-specific antigen in urologic pathology. Preliminary results].
Morote Robles J; Genollar Subirats J
Arch Esp Urol; 1985; 38(6):562-6. PubMed ID: 2421651
[No Abstract] [Full Text] [Related]
19. Evaluation of techniques for diagnosis of canine prostatic diseases.
Barsanti JA; Finco DR
J Am Vet Med Assoc; 1984 Jul; 185(2):198-200. PubMed ID: 6204960
[TBL] [Abstract][Full Text] [Related]
20. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
